Video from the Webinar “Risk Based Monitoring and The IRB: Convergence and Opportunities”

The Webinar conducted by Andy Lawton (Global Head of Data Management at Boehringer Ingelheim) and Ellen Kelso (Executive Director at Chesapeake IRB)

By Artem Andrianov, Ph.D., MBA|2016-11-16T18:35:29+02:00August 17, 2016|Blog|0 Comments

About the Author: Artem Andrianov, Ph.D., MBA

Professional in the integration of data-driven Risk-based Quality Management (RBQM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, Health 2.0, DGGF, etc. 18+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RBQM research to new frontiers for CROs, pharma and biotech companies.